An easy method for efficiently identifying proteins that interact with bioactive molecules has been developed by chemical biologists at RIKEN. This innovation, published in ChemBioChem, could help to ...

How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...

Messenger RNA (mRNA) vaccine technology, which rose to prominence during the Covid-19 pandemic, is now being repurposed by South African scientists to tackle one of the world’s oldest ...

Fact check: HHS misleads on mRNA vaccine safety after pulling Moderna funding The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by ...

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at the University of Pittsburgh School ...

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a new study.

About Strand Therapeutics Strand Therapeutics is a clinical-stage biotechnology company developing programmable mRNA therapeutics to transform the treatment of cancer and other serious diseases.

GenScript’s GMP-like mRNA service provides a strategic solution—bridging the gap between discovery and clinical readiness.

About Strand Therapeutics Strand Therapeutics is a next-generation biotechnology company committed to transforming the lives of patients by developing first-in-class programmable mRNA therapeutics.

In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives. That same mRNA-powered approach to medicine—in which synthetic mRNA is ...

mRNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there.

Researchers have identified cellular factors that regulate the delivery and stability of mRNA to expand the potential of mRNA therapeutics.